BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 32127478)

  • 1. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.
    Na TY; Schecterson L; Mendonsa AM; Gumbiner BM
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5931-5937. PubMed ID: 32127478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
    Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
    Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Heterogeneity and Metastasis of Breast Cancer Cells.
    Hapach LA; Carey SP; Schwager SC; Taufalele PV; Wang W; Mosier JA; Ortiz-Otero N; McArdle TJ; Goldblatt ZE; Lampi MC; Bordeleau F; Marshall JR; Richardson IM; Li J; King MR; Reinhart-King CA
    Cancer Res; 2021 Jul; 81(13):3649-3663. PubMed ID: 33975882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.
    Hazan RB; Phillips GR; Qiao RF; Norton L; Aaronson SA
    J Cell Biol; 2000 Feb; 148(4):779-90. PubMed ID: 10684258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients.
    Bock C; Rack B; Huober J; Andergassen U; Jeschke U; Doisneau-Sixou S
    Future Oncol; 2014 Aug; 10(10):1751-65. PubMed ID: 25303055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles for E-cadherin cell surface regulation in cancer.
    Petrova YI; Schecterson L; Gumbiner BM
    Mol Biol Cell; 2016 Nov; 27(21):3233-3244. PubMed ID: 27582386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.
    Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R
    Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
    Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells.
    Palen K; Weber J; Dwinell MB; Johnson BD; Ramchandran R; Gershan JA
    Oncotarget; 2016 Jul; 7(28):43363-43375. PubMed ID: 27270319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Ca
    Dang DK; Makena MR; Llongueras JP; Prasad H; Ko M; Bandral M; Rao R
    Mol Cancer Res; 2019 Aug; 17(8):1735-1747. PubMed ID: 31076498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen.
    Zheng X; Chen Y; Bai M; Liu Y; Xu B; Sun R; Zeng H
    Free Radic Biol Med; 2019 Feb; 131():7-17. PubMed ID: 30496814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.
    Zhang H; Meng F; Wu S; Kreike B; Sethi S; Chen W; Miller FR; Wu G
    Cancer Res; 2011 Jul; 71(14):4846-56. PubMed ID: 21750175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
    Arima Y; Inoue Y; Shibata T; Hayashi H; Nagano O; Saya H; Taya Y
    Cancer Res; 2008 Jul; 68(13):5104-12. PubMed ID: 18593909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1α,25-Dihydroxyvitamin D Inhibits the Metastatic Capability of MCF10CA1a and MDA-MB-231 Cells in an In Vitro Model of Breast to Bone Metastasis.
    Wilmanski T; Barnard A; Parikh MR; Kirshner J; Buhman K; Burgess J; Teegarden D
    Nutr Cancer; 2016 Oct; 68(7):1202-9. PubMed ID: 27552186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells.
    Huaman J; Naidoo M; Zang X; Ogunwobi OO
    Cells; 2019 Jun; 8(6):. PubMed ID: 31226820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
    Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
    Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.